At the South Carolina Retina Institute (SCRI), we prioritize personalized care and stay at the forefront of medical advancements to offer our patients the best solutions for vision disorders.
Treatment for Retinal Vein Occlusion at South Carolina Retina Institute
South Carolina Retina Institute (SCRI) can offer patients the latest advancement in the treatment of retinal vein occlusion (RVO) – the FDA-approved Genentech’s VABYSMO® (faricimab-svoa).
Advanced Care and Treatment for Macular Edema Associated with Uveitis
South Carolina Retina Institute (SCRI) may, for certain patient eye conditions, administer XIPERE® – a revolutionary therapeutic eye treatment that received FDA approval in October 2021.